Multiple Sclerosis

Landtblom AM , Flodin U , Soderfeldt B Organic solvents and multiple sclerosis: a synthesis of the current evidence. Epidemiology. 1996; 7: 429–33.

Crinnion WJ . Results of a decade of naturopathic treatment for environmental illnesses: a review of clinical records. J Naturopathic Med. 1997; 7(2): 21–7.

Swank RL . Treatment of multiple sclerosis with low-fat diet: result of seven years of experience. Ann Intern Med. 1956; 45: 812–24.

Swank RL , Bourdillon RB . Multiple sclerosis: assessment of treatment with a modified low-fat diet. J Nerv Ment Dis. 1960; 131: 468–88.

Swank RL . Multiple sclerosis: twenty years on low fat diet. Arch Neurol. 1970; 23: 46074.

Swank RL , Grimsgaard A . Multiple sclerosis: the lipid relationship. Am J Clin Nutr. 1988; 48: 1387–93.

Swank RL . Multiple sclerosis: fat-oil relationship. Nutrition. 1991; 7: 368–76.

Swank RL , Dugan BB . Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet. 1990; 336: 37–9.

Swank RL , Goodwin J . Review of MS patient survival on a Swank low saturated fat diet. Nutrition. 2003; 19: 161–2.

Nordvik I , Myhr KM , Nyland H , Bjerve KS . Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol Scand. 2000; 102: 143–9.

Weinstock-Guttman B , Baier M , Park Y Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot Essent Fatty Acids. 2005; 73: 397–404.

Meyer MG , Johnston A , Coca AF . Is multiple sclerosis a manifestation of idioblaptic allergy? Psychiatr Q. 1954(Jan);28:57–71.

Jonez HD . The allergic aspects of multiple sclerosis. Calif Med. 1953; 79: 376–80.

Ehrentheil OF , Schulman MH , Alexander L . Role of food allergy in multiple sclerosis. Neurology. 1952; 2: 412–26.

Maas AG , Hogenhuis LAH . Multiple sclerosis and possible relationship to cocoa: a hypothesis. Ann Allergy. 1987; 59: 76–9.

Lange LS , Shiner M . Small-bowel abnormalities in multiple sclerosis. Lancet. 1976; 2: 1319–22.

Jellinek EH . Multiple sclerosis and diet. Lancet. 1974; 2: 1006–7.

Malosse D , Perron H , Sasco A , Seigneurin JM . Correlation between milk and dairy product consumption and multiple sclerosis prevalence: a worldwide study. Neuroepidemiology. 1992; 11: 304–12.

Ag JBD . The distribution of multiple sclerosis in relation to the dairy industry and milk consumption. N Z Med J. 1976; 83: 427–30.

Agranoff BW , Goldberg D . Diet and the geographical distribution of multiple sclerosis. Lancet. 1974; 2: 1061–6.

Miller SL , Klurfeld DM , Loftus B , Kritchevsky D . Effect of essential fatty acid deficiency on myelin proteins. Lipids. 1984; 19: 478–80.

Wiggins RC . Myelin development and nutritional insufficiency. Brain Res Rev. 1982; 4: 151–75.

Clausen J , Moller J . Allergic encephalomyelitis induced by brain antigen after deficiency in polyunsaturated fatty acids during myelination. Acta Neurol Scand. 1967; 43: 375–88.

Selivonchick DP , Johnston PV . Fat deficiency in rats during development of the central nervous system and susceptibility to experimental allergic encephalomyelitis. J Nutr. 1975; 105: 288–300.

Levine S , Sowinski R . Effect of essential fatty acid deficiency on experimental allergic encephalomyelitis in rats. J Nutr. 1980; 110: 891–6.

Hughes D , Keith AB , Mertin J , Caspary EA . Linoleic acid therapy in severe experimental allergic encephalomyelitis in the guinea-pig: suppression by continuous treatment. Clin Exp Immunol. 1980; 41: 523–31.

Baker RWR , Thompson RHS , Zilkha KJ . Serum fatty acids in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1964; 27: 408–14.

Belin J , Pettet N , Smith AD Linoleate metabolism in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1971; 34: 25–9.

Tsang WM , Belin J , Monro JA Relationship between plasma and lymphocyte linoleate in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1976; 39: 767–71.

Navarro X , Segura R . Plasma lipids and their fatty acid composition in multiple sclerosis. Acta Neurol Scand. 1988; 78: 152–7.

Love WC , Cashell A , Reynolds M , Callaghan N . Linoleate and fatty-acid patterns of serum lipids in multiple sclerosis and other diseases. Br Med J. 1974; 3: 18–21.

Neu IS . Essential fatty acids in the serum and cerebrospinal fluid of multiple sclerosis patients. Acta Neurol Scand. 1983; 67: 151–63.

Yoshida M , Takase S , Itahara K , Nakanishi T . Linoleate and fatty acid compositions in the serum lipids of Japanese patients with multiple sclerosis. Acta Neurol Scand. 1983; 68: 362–4.

Gupta JK , Ingegno AP , Cook AW , Pertschuk LP . Multiple sclerosis and malabsorption. Am J Gastroenterol. 1977; 68: 560–5.

Joyce G , Field EJ . Further observations with the erythrocyte-unsaturated fatty acid test. Eur Neurol. 1980; 19: 266–72.

Field EJ , Shenton BK . Inhibitory effect of unsaturated fatty acids on lymphocyte-antigen interaction with special reference to multiple sclerosis. Acta Neurol Scand. 1975; 52: 121–36.

Field EJ , Shenton BK , Joyce G . Specific laboratory test for diagnosis of multiple sclerosis. Br Med J. 1974; 1: 412–4.

Tamblyn CH , Swank RL , Seaman GVF , Zukoski CF IV . Red cell electrophoretic mobility test for early diagnosis of multiple sclerosis. Neurol Res. 1980; 2: 69–83.

Field EJ , Joyce G . Multiple sclerosis: effect of gamma linolenate administration upon membranes and the need for extended clinical trials of unsaturated fatty acids. Eur Neurol. 1983; 22: 78–83.

Field EJ , Joyce G . Effect of prolonged ingestion of gamma-linolenate by MS patients. Eur Neurol. 1978; 17: 67–76.

Millar JHD , Zilkha KJ , Langman MJS Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Br Med J. 1973; 1: 765–8.

Bates D , Fawcett PRW , Shaw DA , Weightman D . Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis. Br Med J. 1978; 2: 1390–1.

Paty DW , Cousin HK , Read S , Adlakha K . Linoleic acid in multiple sclerosis: failure to show any therapeutic benefit. Acta Neurol Scand. 1978; 58: 53–8.

Bates D , Fawcett PRW , Shaw DA , Weightman D . Trial of polyunsaturated fatty acids in non-relapsing multiple sclerosis. Br Med J. 1977; 2: 932–3.

Dworkin RH , Bates D , Millar JHD , Paty DW . Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials. Neurology. 1984; 34: 1441–5.

Nightingale S , Woo E , Smith AD Red blood cell and adipose tissue fatty acids in mild inactive multiple sclerosis. Acta Neurol Scand. 1990; 82: 43–50.

Cendrowski W . Multiple sclerosis and MaxEPA. Br J Clin Pract. 1986; 40: 365–7.

Goldberg P , Fleming MC , Picard EH . Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses. 1986; 21: 193–200.

Bates D , Cartlidge NEF , French JM A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry. 1989; 52: 18–22.

Reynolds EH , Linnell JC . Vitamin B12 deficiency, demyelination, and multiple sclerosis. Lancet. 1987; 2: 920.

Reynolds EH . Multiple sclerosis and vitamin B12 metabolism. J Neuroimmunol. 1992; 40: 225–30.

Reynolds EH , Linnell JC , Faludy JE . Multiple sclerosis associated with vitamin B12 deficiency. Arch Neurol. 1991; 48: 808–11.

Kira J , Tobimatsu S , Goto I . Vitamin B12 metabolism and massive-dose methyl vitamin B12 therapy in Japanese patients with multiple sclerosis. Intern Med. 1994; 33: 82–6.

Anonymous. Vitamin B12 in multiple sclerosis. JAMA. 1950; 143: 1272.

Wade DT , Young CA , Chaudhuri KR , Davidson DLW . A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the “Cari Loder regime”) in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry. 2002; 73: 246–9.

Booth CB , Lawyer T Jr , von Storch TJC . Vitamin B12 in the treatment of multiple sclerosis. JAMA. 1951; 147: 894.

Lebrun C , Alchaar H , Candito M Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue. Mult Scler. 2006; 12: 321–4.

Tomassini V , Pozzilli C , Onesti E Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial. J Neurol Sci. 2004; 218: 103–8.

Hayes CE , Cantorna MT , DeLuca HF . Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med. 1997; 216: 21–7.

Cantorna MT . Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc Soc Exp Biol Med. 2000; 223: 230–3.

Munger KL , Zhang SM , O'Reilly E Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004; 62: 60–5.

Cantorna MT , Hayes CE , DeLuca HF . 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci. 1996; 93: 7861–4.

Nieves J , Cosman F , Herbert J High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology. 1994; 44: 1687–92.

Kimball SM , Ursell MR , O'Connor P , Vieth R . Safety of vitamin D3 in adults with multiple sclerosis. Am J Clin Nutr. 2007; 86: 645–51.

Burton JM , Kimball S , Vieth R A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology. 2010; 74: 1852–9.

Soilu-Hanninen M , Aivo J , Lindstrom BM A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon beta-1b in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2012; 83: 565–71.

Stein MS , Liu Y , Gray OM A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology. 2011; 77: 1611–8.

Kaneko S , Wang J , Kaneko M Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models. J Neurosci. 2006; 26: 9794–804.

Lee KC , Patterson V , Roberts G , Trimble E . The antispastic effect of L-threonine. In: Lubec and Rosenthal , editors. Amino acids: chemistry, biology and medicine. Berlin, Heidelberg: Springer; 1990: 658–63.

Lee A , Patterson V . A double-blind study of L-threonine in patients with spinal spasticity. Acta Neurol Scand. 1993; 88: 334–8.

Hauser SL , Doolittle TH , Lopez-Bresnahan M An antispasticity effect of threonine in multiple sclerosis. Arch Neurol. 1992; 49: 923–6.

Isager H . Serum folate in patients with multiple sclerosis. Acta Neurol Scand. 1970; 46: 238–42.

Heathcote JG . Multiple sclerosis. Lancet. 1975; 1: 344.

Becker KW , Kienecker EW , Dick P , Bonke D . Enhancement of regeneration of the saphenous nerve after treatment with vitamins B1, B6, and B12 after cold lesion in the rabbit. Ann N Y Acad Sci. 1990; 585: 477–9.

Wiggins RC . Myelin development and nutritional insufficiency. Brain Res Rev. 1982; 4: 151–75.

Zimmerman AW , Matthieu JM , Quarles RH Hypomyelination in copper-deficient rats. Prenatal and postnatal copper replacement. Arch Neurol. 1976; 33: 111–9.

Truss CO . The role of Candida albicans in human illness. J Orthomolec Psychiatry. 1981; 10: 228–38.

Crook W . The yeast connection. Jackson, TN: Professional Books; 1986: 211–9.

Zouali M , Drouhet E , Eyquem A . Evaluation of auto-antibodies in chronic mucocutaneous candidiasis without endocrinopathy. Mycopathologia. 1983; 84: 87–93.

Gay D , Dick G , Upton G . Multiple sclerosis associated with sinusitis: case-controlled study in general practice. Lancet. 1986; 1: 815–9.

Sicotte NL , Liva SM , Klutch R Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol. 2002; 52: 421–8.

Kuempfel T , Then Bergh F , Friess E Neuroendocrine-immune system interactions: dehydroepiandrosterone plasma levels in multiple sclerosis. Ann Neurol. 1997; 42: 428.

Kumpfel T , Then Bergh F , Friess E Dehydroepiandrosterone response to the adrenocorticotropin test and the combined dexamethasone and corticotropin-releasing hormone test in patients with multiple sclerosis. Neuroendocrinology. 1999; 70: 431–8.

Tellez N , Comabella M , Julia E Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone. Mult Scler. 2006; 12: 487–94.

Korwin-Piotrowska T , Nocon D , Stankowska-Chomicz A Experience of Padma 28 in multiple sclerosis. Phytother Res. 1992; 6: 133–6.

Lowry ML , Moore RW , Cailliet R . Adenosine-5-monophosphate in the treatment of multiple sclerosis. Am J Med Sci. 1953; 226: 73–83.